Revolutionary AI-powered collaboration combines Iambic’s NeuralPLexer with Revolution’s oncology expertise to tackle challenging drug targets. Learn breakthrough details.
Revolution Medicines Taps Iambic's AI Platform in $25M Deal to Accelerate Cancer Drug Discovery
